Back to search

France· FR:63865537

GENCEBOK 10 mg/mL, solution pour perfusion

A medicinal product containing citrate de caféine, registered in France by GENNISIUM PHARMA.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGENCEBOK 10 mg/mL, solution pour perf…ATC—REGISTER NO.FR:63865537PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CITRATE DE CAFÉINE
Manufacturer
GENNISIUM PHARMA
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955078197
    50 ampoule(s) en verre de 1 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Citrate de caféine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All citrate de caféine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Coffekapton
  • Belgium · Cafeine Sterop
  • Germany · Coffeinum N, Percoffedrinol N Aristo
  • Spain · Durvitan
  • United Kingdom (Northern Ireland) · Caffeine Citrate, Caffeine Citrate Brown & Burk Uk
  • Hungary · Coffeini Fono Viii. Naturland
  • Iceland · Gencebok, Peyona
  • Italy · Caffeina Citrato Monico
  • Liechtenstein · Gencebok, Peyona
  • Malta · Caffeine Citrate Monico
  • Norway · Gencebok, Peyona
  • Sweden · Koffein Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9ceaae3-8667-4dc1-8d17-ae1764f72f3f
GET /v1/drugs/a9ceaae3-8667-4dc1-8d17-ae1764f72f3f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63865537",
  "date_amm": "2020-08-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/20/1465",
  "substance": "CITRATE DE CAFÉINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "intraveineuse;orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about citrate de caféine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.